Clinical Study results indicate the potential ability of Glow Lifetech's ArtemiC Support® to reduce symptoms of Post-Acute COVID Syndrome (Long COVID).Study results demonstrate the statistically significant
Toronto, Ontario (Newsfile Corp. - July 14, 2022) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), is pleased to announce that it has extended the expiry date of